VJOncology is committed to improving our service to you

EAU 2020 | EUPROMS: prostate cancer patient-driven QoL

VJOncology is committed to improving our service to you

André Deschamps

André Deschamps, of Europa Uomo, Antwerpen, Belgium, discusses the effect of prostate cancer treatment as evaluated in the EUPROMS study, the first ever patient driven quality of life (QoL) study. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter